Table of Content

1 Report Overview
1.1 Oxycodone Drug Definition
1.2 Market by Type
1.2.1 Global Oxycodone Drug Market Size Growth Rate by Type, 2018 VS 2024 VS 2034
1.2.2 Pain Management
1.2.3 Anesthesia
1.2.4 Others
1.3 Market Segment by Application
1.3.1 Global Oxycodone Drug Market Size Growth Rate by Application, 2018 VS 2024 VS 2034
1.3.2 Hospitals & Clinics
1.3.3 Ambulatory Surgical Centers (ASCs)
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Oxycodone Drug Sales
2.1 Global Oxycodone Drug Revenue Estimates and Forecasts 2018-2034
2.2 Global Oxycodone Drug Revenue by Region: 2018 VS 2024 VS 2034
2.3 Global Oxycodone Drug Revenue by Region
2.3.1 Global Oxycodone Drug Revenue by Region (2018-2023)
2.3.2 Global Oxycodone Drug Revenue by Region (2024-2034)
2.4 Global Oxycodone Drug Sales Quantity Estimates and Forecasts 2018-2034
2.5 Global Oxycodone Drug Sales Quantity by Region: 2018 VS 2024 VS 2034
2.6 Global Oxycodone Drug Sales Quantity by Region
2.6.1 Global Oxycodone Drug Sales Quantity by Region (2018-2023)
2.6.2 Global Oxycodone Drug Sales Quantity by Region (2024-2034)
2.7 North America
2.8 Europe
2.9 China
2.10 APAC (excluding China)
2.11 Middle East, Africa and Latin America
3 Competition by Manufacturers
3.1 Global Oxycodone Drug Sales Quantity by Manufacturers
3.1.1 Global Oxycodone Drug Sales Quantity by Manufacturers (2018-2023)
3.1.2 Global Oxycodone Drug Sales Quantity Share by Manufacturers (2018-2023)
3.1.3 Global Top 10 and Top 5 Companies by Oxycodone Drug Sales in 2024
3.2 Global Oxycodone Drug Revenue by Manufacturers
3.2.1 Global Oxycodone Drug Revenue by Manufacturers (2018-2023)
3.2.2 Global Oxycodone Drug Revenue Share by Manufacturers (2018-2023)
3.2.3 Global Top 10 and Top 5 Companies by Oxycodone Drug Revenue in 2024
3.3 Global Oxycodone Drug Sales Price by Manufacturers
3.4 Global Key Players of Oxycodone Drug, Industry Ranking, 2021 VS 2024
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Oxycodone Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Oxycodone Drug, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Oxycodone Drug, Product Offered and Application
3.8 Global Key Manufacturers of Oxycodone Drug, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Estimates and Forecasts by Type
4.1 Global Oxycodone Drug Sales Quantity by Type
4.1.1 Global Oxycodone Drug Historical Sales Quantity by Type (2018-2023)
4.1.2 Global Oxycodone Drug Forecasted Sales Quantity by Type (2024-2034)
4.1.3 Global Oxycodone Drug Sales Quantity Market Share by Type (2018-2034)
4.2 Global Oxycodone Drug Revenue by Type
4.2.1 Global Oxycodone Drug Historical Revenue by Type (2018-2023)
4.2.2 Global Oxycodone Drug Forecasted Revenue by Type (2024-2034)
4.2.3 Global Oxycodone Drug Revenue Market Share by Type (2018-2034)
4.3 Global Oxycodone Drug Price by Type
4.3.1 Global Oxycodone Drug Price by Type (2018-2023)
4.3.2 Global Oxycodone Drug Price Forecast by Type (2024-2034)
5 Market Size by Application
5.1 Global Oxycodone Drug Sales Quantity by Application
5.1.1 Global Oxycodone Drug Historical Sales Quantity by Application (2018-2023)
5.1.2 Global Oxycodone Drug Forecasted Sales Quantity by Application (2024-2034)
5.1.3 Global Oxycodone Drug Sales Quantity Market Share by Application (2018-2034)
5.2 Global Oxycodone Drug Revenue by Application
5.2.1 Global Oxycodone Drug Historical Revenue by Application (2018-2023)
5.2.2 Global Oxycodone Drug Forecasted Revenue by Application (2024-2034)
5.2.3 Global Oxycodone Drug Revenue Market Share by Application (2018-2034)
5.3 Global Oxycodone Drug Price by Application
5.3.1 Global Oxycodone Drug Price by Application (2018-2023)
5.3.2 Global Oxycodone Drug Price Forecast by Application (2024-2034)
6 North America
6.1 North America Oxycodone Drug Sales by Company
6.1.1 North America Oxycodone Drug Revenue by Company (2018-2023)
6.1.2 North America Oxycodone Drug Sales Quantity by Company (2018-2023)
6.2 North America Oxycodone Drug Market Size by Type
6.2.1 North America Oxycodone Drug Sales Quantity by Type (2018-2034)
6.2.2 North America Oxycodone Drug Revenue by Type (2018-2034)
6.3 North America Oxycodone Drug Market Size by Application
6.3.1 North America Oxycodone Drug Sales Quantity by Application (2018-2034)
6.3.2 North America Oxycodone Drug Revenue by Application (2018-2034)
6.4 North America Oxycodone Drug Market Size by Country
6.4.1 North America Oxycodone Drug Revenue by Country: 2018 VS 2024 VS 2034
6.4.2 North America Oxycodone Drug Revenue by Country (2018-2034)
6.4.3 North America Oxycodone Drug Sales Quantity by Country (2018-2034)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe Oxycodone Drug Sales by Company
7.1.1 Europe Oxycodone Drug Sales Quantity by Company (2018-2023)
7.1.2 Europe Oxycodone Drug Revenue by Company (2018-2023)
7.2 Europe Oxycodone Drug Market Size by Type
7.2.1 Europe Oxycodone Drug Sales Quantity by Type (2018-2034)
7.2.2 Europe Oxycodone Drug Revenue by Type (2018-2034)
7.3 Europe Oxycodone Drug Market Size by Application
7.3.1 Europe Oxycodone Drug Sales Quantity by Application (2018-2034)
7.3.2 Europe Oxycodone Drug Revenue by Application (2018-2034)
7.4 Europe Oxycodone Drug Market Size by Country
7.4.1 Europe Oxycodone Drug Revenue by Country: 2018 VS 2024 VS 2034
7.4.2 Europe Oxycodone Drug Revenue by Country (2018-2034)
7.4.3 Europe Oxycodone Drug Sales Quantity by Country (2018-2034)
7.4.4 Germany
7.4.5 France
7.4.6 U.K.
7.4.7 Italy
7.4.8 Russia
8 China
8.1 China Oxycodone Drug Sales by Company
8.1.1 China Oxycodone Drug Sales Quantity by Company (2018-2023)
8.1.2 China Oxycodone Drug Revenue by Company (2018-2023)
8.2 China Oxycodone Drug Market Size by Type
8.2.1 China Oxycodone Drug Sales Quantity by Type (2018-2034)
8.2.2 China Oxycodone Drug Revenue by Type (2018-2034)
8.3 China Oxycodone Drug Market Size by Application
8.3.1 China Oxycodone Drug Sales Quantity by Application (2018-2034)
8.3.2 China Oxycodone Drug Revenue by Application (2018-2034)
9 APAC (excluding China)
9.1 APAC Oxycodone Drug Sales by Company
9.1.1 APAC Oxycodone Drug Sales Quantity by Company (2018-2023)
9.1.2 APAC Oxycodone Drug Revenue by Company (2018-2023)
9.2 APAC Oxycodone Drug Market Size by Type
9.2.1 APAC Oxycodone Drug Sales Quantity by Type (2018-2034)
9.2.2 APAC Oxycodone Drug Revenue by Type (2018-2034)
9.3 APAC Oxycodone Drug Market Size by Application
9.3.1 APAC Oxycodone Drug Sales Quantity by Application (2018-2034)
9.3.2 APAC Oxycodone Drug Revenue by Application (2018-2034)
9.4 APAC Oxycodone Drug Market Size by Region
9.4.1 APAC Oxycodone Drug Revenue by Region: 2018 VS 2024 VS 2034
9.4.2 APAC Oxycodone Drug Revenue by Region (2018-2034)
9.4.3 APAC Oxycodone Drug Sales Quantity by Region (2018-2034)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Oxycodone Drug Sales by Company
10.1.1 Middle East, Africa and Latin America Oxycodone Drug Sales Quantity by Company (2018-2023)
10.1.2 Middle East, Africa and Latin America Oxycodone Drug Revenue by Company (2018-2023)
10.2 Middle East, Africa and Latin America Oxycodone Drug Market Size by Type
10.2.1 Middle East, Africa and Latin America Oxycodone Drug Sales Quantity by Type (2018-2034)
10.2.2 Middle East, Africa and Latin America Oxycodone Drug Revenue by Type (2018-2034)
10.3 Middle East, Africa and Latin America Oxycodone Drug Market Size by Application
10.3.1 Middle East, Africa and Latin America Oxycodone Drug Sales Quantity by Application (2018-2034)
10.3.2 Middle East, Africa and Latin America Oxycodone Drug Revenue by Application (2018-2034)
10.4 Middle East, Africa and Latin America Oxycodone Drug Market Size by Country
10.4.1 Middle East, Africa and Latin America Oxycodone Drug Revenue by Country: 2018 VS 2024 VS 2034
10.4.2 Middle East, Africa and Latin America Oxycodone Drug Revenue by Country (2018-2034)
10.4.3 Middle East, Africa and Latin America Oxycodone Drug Sales Quantity by Country (2018-2034)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Israel
10.4.8 GCC Countries
11 Company Profiles
11.1 Purdue Pharma L.P
11.1.1 Purdue Pharma L.P Company Information
11.1.2 Purdue Pharma L.P Overview
11.1.3 Purdue Pharma L.P Oxycodone Drug Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.1.4 Purdue Pharma L.P Oxycodone Drug Products and Services
11.1.5 Purdue Pharma L.P Oxycodone Drug SWOT Analysis
11.1.6 Purdue Pharma L.P Recent Developments
11.2 Janssen Pharmaceuticals(Johnson & Johnson)
11.2.1 Janssen Pharmaceuticals(Johnson & Johnson) Company Information
11.2.2 Janssen Pharmaceuticals(Johnson & Johnson) Overview
11.2.3 Janssen Pharmaceuticals(Johnson & Johnson) Oxycodone Drug Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.2.4 Janssen Pharmaceuticals(Johnson & Johnson) Oxycodone Drug Products and Services
11.2.5 Janssen Pharmaceuticals(Johnson & Johnson) Oxycodone Drug SWOT Analysis
11.2.6 Janssen Pharmaceuticals(Johnson & Johnson) Recent Developments
11.3 Hikma Pharmaceuticals USA
11.3.1 Hikma Pharmaceuticals USA Company Information
11.3.2 Hikma Pharmaceuticals USA Overview
11.3.3 Hikma Pharmaceuticals USA Oxycodone Drug Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.3.4 Hikma Pharmaceuticals USA Oxycodone Drug Products and Services
11.3.5 Hikma Pharmaceuticals USA Oxycodone Drug SWOT Analysis
11.3.6 Hikma Pharmaceuticals USA Recent Developments
11.4 Pfizer
11.4.1 Pfizer Company Information
11.4.2 Pfizer Overview
11.4.3 Pfizer Oxycodone Drug Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.4.4 Pfizer Oxycodone Drug Products and Services
11.4.5 Pfizer Oxycodone Drug SWOT Analysis
11.4.6 Pfizer Recent Developments
11.5 Sanofi-Aventis S.A.
11.5.1 Sanofi-Aventis S.A. Company Information
11.5.2 Sanofi-Aventis S.A. Overview
11.5.3 Sanofi-Aventis S.A. Oxycodone Drug Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.5.4 Sanofi-Aventis S.A. Oxycodone Drug Products and Services
11.5.5 Sanofi-Aventis S.A. Oxycodone Drug SWOT Analysis
11.5.6 Sanofi-Aventis S.A. Recent Developments
11.6 Sun Pharmaceutical Industries Ltd.
11.6.1 Sun Pharmaceutical Industries Ltd. Company Information
11.6.2 Sun Pharmaceutical Industries Ltd. Overview
11.6.3 Sun Pharmaceutical Industries Ltd. Oxycodone Drug Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.6.4 Sun Pharmaceutical Industries Ltd. Oxycodone Drug Products and Services
11.6.5 Sun Pharmaceutical Industries Ltd. Oxycodone Drug SWOT Analysis
11.6.6 Sun Pharmaceutical Industries Ltd. Recent Developments
11.7 Oxynorm
11.7.1 Oxynorm Company Information
11.7.2 Oxynorm Overview
11.7.3 Oxynorm Oxycodone Drug Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.7.4 Oxynorm Oxycodone Drug Products and Services
11.7.5 Oxynorm Oxycodone Drug SWOT Analysis
11.7.6 Oxynorm Recent Developments
11.8 OxyContin
11.8.1 OxyContin Company Information
11.8.2 OxyContin Overview
11.8.3 OxyContin Oxycodone Drug Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.8.4 OxyContin Oxycodone Drug Products and Services
11.8.5 OxyContin Oxycodone Drug SWOT Analysis
11.8.6 OxyContin Recent Developments
11.9 Endone
11.9.1 Endone Company Information
11.9.2 Endone Overview
11.9.3 Endone Oxycodone Drug Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.9.4 Endone Oxycodone Drug Products and Services
11.9.5 Endone Oxycodone Drug SWOT Analysis
11.9.6 Endone Recent Developments
11.10 Proladone
11.10.1 Proladone Company Information
11.10.2 Proladone Overview
11.10.3 Proladone Oxycodone Drug Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.10.4 Proladone Oxycodone Drug Products and Services
11.10.5 Proladone Oxycodone Drug SWOT Analysis
11.10.6 Proladone Recent Developments
11.11 Targin
11.11.1 Targin Company Information
11.11.2 Targin Overview
11.11.3 Targin Oxycodone Drug Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.11.4 Targin Oxycodone Drug Products and Services
11.11.5 Targin Recent Developments
12 Value Chain and Sales Channels Analysis
12.1 Oxycodone Drug Value Chain Analysis
12.2 Oxycodone Drug Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Oxycodone Drug Production Mode & Process
12.4 Oxycodone Drug Sales and Marketing
12.4.1 Oxycodone Drug Sales Channels
12.4.2 Oxycodone Drug Distributors
12.5 Oxycodone Drug Customers
13 Market Dynamics
13.1 Oxycodone Drug Industry Trends
13.2 Oxycodone Drug Market Drivers
13.3 Oxycodone Drug Market Challenges
13.4 Oxycodone Drug Market Restraints
14 Key Findings
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Oxycodone Drug Market Size Growth Rate (CAGR) by Type, 2018 VS 2024 VS 2034 (US$ Million)
Table 2. Major Manufacturers of Pain Management
Table 3. Major Manufacturers of Anesthesia
Table 4. Major Manufacturers of Others
Table 5. Global Oxycodone Drug Market Size Growth Rate (CAGR) by Application, 2018 VS 2024 VS 2034 (US$ Million)
Table 6. Global Oxycodone Drug Revenue by Region: 2018 VS 2024 VS 2034 (US$ Million)
Table 7. Global Oxycodone Drug Revenue by Region (2018-2023) & (US$ Million)
Table 8. Global Oxycodone Drug Revenue Market Share by Region (2018-2023)
Table 9. Global Oxycodone Drug Revenue by Region (2024-2034) & (US$ Million)
Table 10. Global Oxycodone Drug Revenue Market Share by Region (2024-2034)
Table 11. Global Oxycodone Drug Sales Quantity by Region: 2018 VS 2024 VS 2034 (K Units)
Table 12. Global Oxycodone Drug Sales by Region (2018-2023) & (K Units)
Table 13. Global Oxycodone Drug Sales Market Share by Region (2018-2023)
Table 14. Global Oxycodone Drug Sales by Region (2024-2034) & (K Units)
Table 15. Global Oxycodone Drug Sales Market Share by Region (2024-2034)
Table 16. Global Oxycodone Drug Sales Quantity by Manufacturers (2018-2023) & (K Units)
Table 17. Global Oxycodone Drug Sales Quantity Share by Manufacturers (2018-2023)
Table 18. Global Oxycodone Drug Revenue by Manufacturers (2018-2023) & (US$ Million)
Table 19. Global Oxycodone Drug Revenue Share by Manufacturers (2018-2023)
Table 20. Global Oxycodone Drug Price by Manufacturers 2018-2023 (USD/Unit)
Table 21. Global Key Players of Oxycodone Drug, Industry Ranking, 2021 VS 2024
Table 22. Global Oxycodone Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 23. Global Oxycodone Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Oxycodone Drug as of 2024)
Table 24. Global Key Manufacturers of Oxycodone Drug, Manufacturing Base Distribution and Headquarters
Table 25. Global Key Manufacturers of Oxycodone Drug, Product Offered and Application
Table 26. Global Key Manufacturers of Oxycodone Drug, Date of Enter into This Industry
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Oxycodone Drug Sales Quantity by Type (2018-2023) & (K Units)
Table 29. Global Oxycodone Drug Sales Quantity by Type (2024-2034) & (K Units)
Table 30. Global Oxycodone Drug Sales Quantity Share by Type (2018-2023)
Table 31. Global Oxycodone Drug Sales Quantity Share by Type (2024-2034)
Table 32. Global Oxycodone Drug Revenue by Type (2018-2023) & (US$ Million)
Table 33. Global Oxycodone Drug Revenue by Type (2024-2034) & (US$ Million)
Table 34. Global Oxycodone Drug Revenue Share by Type (2018-2023)
Table 35. Global Oxycodone Drug Revenue Share by Type (2024-2034)
Table 36. Oxycodone Drug Price by Type (2018-2023) & (USD/Unit)
Table 37. Global Oxycodone Drug Price Forecast by Type (2024-2034) & (USD/Unit)
Table 38. Global Oxycodone Drug Sales Quantity by Application (2018-2023) & (K Units)
Table 39. Global Oxycodone Drug Sales Quantity by Application (2024-2034) & (K Units)
Table 40. Global Oxycodone Drug Sales Quantity Share by Application (2018-2023)
Table 41. Global Oxycodone Drug Sales Quantity Share by Application (2024-2034)
Table 42. Global Oxycodone Drug Revenue by Application (2018-2023) & (US$ Million)
Table 43. Global Oxycodone Drug Revenue by Application (2024-2034) & (US$ Million)
Table 44. Global Oxycodone Drug Revenue Share by Application (2018-2023)
Table 45. Global Oxycodone Drug Revenue Share by Application (2024-2034)
Table 46. Oxycodone Drug Price by Application (2018-2023) & (USD/Unit)
Table 47. Global Oxycodone Drug Price Forecast by Application (2024-2034) & (USD/Unit)
Table 48. North America Oxycodone Drug Revenue by Company (2018-2023) & (US$ Million)
Table 49. North America Oxycodone Drug Sales Quantity by Company (2018-2023) & (K Units)
Table 50. North America Oxycodone Drug Sales Quantity by Type (2018-2023) & (K Units)
Table 51. North America Oxycodone Drug Sales Quantity by Type (2024-2034) & (K Units)
Table 52. North America Oxycodone Drug Revenue by Type (2018-2023) & (US$ Million)
Table 53. North America Oxycodone Drug Revenue by Type (2024-2034) & (US$ Million)
Table 54. North America Oxycodone Drug Sales Quantity by Application (2018-2023) & (K Units)
Table 55. North America Oxycodone Drug Sales Quantity by Application (2024-2034) & (K Units)
Table 56. North America Oxycodone Drug Revenue by Application (2018-2023) & (US$ Million)
Table 57. North America Oxycodone Drug Revenue by Application (2024-2034) & (US$ Million)
Table 58. North America Oxycodone Drug Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 59. North America Oxycodone Drug Revenue by Country (2018-2023) & (US$ Million)
Table 60. North America Oxycodone Drug Revenue by Country (2024-2034) & (US$ Million)
Table 61. North America Oxycodone Drug Sales Quantity by Country (2018-2023) & (K Units)
Table 62. North America Oxycodone Drug Sales Quantity by Country (2024-2034) & (K Units)
Table 63. Europe Oxycodone Drug Sales Quantity by Company (2018-2023) & (K Units)
Table 64. Europe Oxycodone Drug Revenue by Company (2018-2023) & (US$ Million)
Table 65. Europe Oxycodone Drug Sales Quantity by Type (2018-2023) & (K Units)
Table 66. Europe Oxycodone Drug Sales Quantity by Type (2024-2034) & (K Units)
Table 67. Europe Oxycodone Drug Revenue by Type (2018-2023) & (US$ Million)
Table 68. Europe Oxycodone Drug Revenue by Type (2024-2034) & (US$ Million)
Table 69. Europe Oxycodone Drug Sales Quantity by Application (2018-2023) & (K Units)
Table 70. Europe Oxycodone Drug Sales Quantity by Application (2024-2034) & (K Units)
Table 71. Europe Oxycodone Drug Revenue by Application (2018-2023) & (US$ Million)
Table 72. Europe Oxycodone Drug Revenue by Application (2024-2034) & (US$ Million)
Table 73. Europe Oxycodone Drug Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 74. Europe Oxycodone Drug Revenue by Country (2018-2023) & (US$ Million)
Table 75. Europe Oxycodone Drug Revenue by Country (2024-2034) & (US$ Million)
Table 76. Europe Oxycodone Drug Sales Quantity by Country (2018-2023) & (K Units)
Table 77. Europe Oxycodone Drug Sales Quantity by Country (2024-2034) & (K Units)
Table 78. China Oxycodone Drug Sales Quantity by Company (2018-2023) & (K Units)
Table 79. China Oxycodone Drug Revenue by Company (2018-2023) & (US$ Million)
Table 80. China Oxycodone Drug Sales Quantity by Type (2018-2023) & (K Units)
Table 81. China Oxycodone Drug Sales Quantity by Type (2024-2034) & (K Units)
Table 82. China Oxycodone Drug Revenue by Type (2018-2023) & (US$ Million)
Table 83. China Oxycodone Drug Revenue by Type (2024-2034) & (US$ Million)
Table 84. China Oxycodone Drug Sales Quantity by Application (2018-2023) & (K Units)
Table 85. China Oxycodone Drug Sales Quantity by Application (2024-2034) & (K Units)
Table 86. China Oxycodone Drug Revenue by Application (2018-2023) & (US$ Million)
Table 87. China Oxycodone Drug Revenue by Application (2024-2034) & (US$ Million)
Table 88. APAC Oxycodone Drug Sales Quantity by Company (2018-2023) & (K Units)
Table 89. APAC Oxycodone Drug Revenue by Company (2018-2023) & (US$ Million)
Table 90. APAC Oxycodone Drug Sales Quantity by Type (2018-2023) & (K Units)
Table 91. APAC Oxycodone Drug Sales Quantity by Type (2024-2034) & (K Units)
Table 92. APAC Oxycodone Drug Revenue by Type (2018-2023) & (US$ Million)
Table 93. APAC Oxycodone Drug Revenue by Type (2024-2034) & (US$ Million)
Table 94. APAC Oxycodone Drug Sales Quantity by Application (2018-2023) & (K Units)
Table 95. APAC Oxycodone Drug Sales Quantity by Application (2024-2034) & (K Units)
Table 96. APAC Oxycodone Drug Revenue by Application (2018-2023) & (US$ Million)
Table 97. APAC Oxycodone Drug Revenue by Application (2024-2034) & (US$ Million)
Table 98. APAC Oxycodone Drug Revenue by Region: 2018 VS 2024 VS 2034 (US$ Million)
Table 99. APAC Oxycodone Drug Revenue by Region (2018-2023) & (US$ Million)
Table 100. APAC Oxycodone Drug Revenue by Region (2024-2034) & (US$ Million)
Table 101. APAC Oxycodone Drug Sales Quantity by Region (2018-2023) & (K Units)
Table 102. APAC Oxycodone Drug Sales Quantity by Region (2024-2034) & (K Units)
Table 103. Middle East, Africa and Latin America Oxycodone Drug Sales Quantity by Company (2018-2023) & (K Units)
Table 104. Middle East, Africa and Latin America Oxycodone Drug Revenue by Company (2018-2023) & (US$ Million)
Table 105. Middle East, Africa and Latin America Oxycodone Drug Sales Quantity by Type (2018-2023) & (K Units)
Table 106. Middle East, Africa and Latin America Oxycodone Drug Sales Quantity by Type (2024-2034) & (K Units)
Table 107. Middle East, Africa and Latin America Oxycodone Drug Revenue by Type (2018-2023) & (US$ Million)
Table 108. Middle East, Africa and Latin America Oxycodone Drug Revenue by Type (2024-2034) & (US$ Million)
Table 109. Middle East, Africa and Latin America Oxycodone Drug Sales Quantity by Application (2018-2023) & (K Units)
Table 110. Middle East, Africa and Latin America Oxycodone Drug Sales Quantity by Application (2024-2034) & (K Units)
Table 111. Middle East, Africa and Latin America Oxycodone Drug Revenue by Application (2018-2023) & (US$ Million)
Table 112. Middle East, Africa and Latin America Oxycodone Drug Revenue by Application (2024-2034) & (US$ Million)
Table 113. Middle East, Africa and Latin America Oxycodone Drug Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 114. Middle East, Africa and Latin America Oxycodone Drug Revenue by Country (2018-2023) & (US$ Million)
Table 115. Middle East, Africa and Latin America Oxycodone Drug Revenue by Country (2024-2034) & (US$ Million)
Table 116. Middle East, Africa and Latin America Oxycodone Drug Sales Quantity by Country (2018-2023) & (K Units)
Table 117. Middle East, Africa and Latin America Oxycodone Drug Sales Quantity by Country (2024-2034) & (K Units)
Table 118. Purdue Pharma L.P Company Information
Table 119. Purdue Pharma L.P Description and Overview
Table 120. Purdue Pharma L.P Oxycodone Drug Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 121. Purdue Pharma L.P Oxycodone Drug Product and Services
Table 122. Purdue Pharma L.P Oxycodone Drug SWOT Analysis
Table 123. Purdue Pharma L.P Recent Developments
Table 124. Janssen Pharmaceuticals(Johnson & Johnson) Company Information
Table 125. Janssen Pharmaceuticals(Johnson & Johnson) Description and Overview
Table 126. Janssen Pharmaceuticals(Johnson & Johnson) Oxycodone Drug Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 127. Janssen Pharmaceuticals(Johnson & Johnson) Oxycodone Drug Product and Services
Table 128. Janssen Pharmaceuticals(Johnson & Johnson) Oxycodone Drug SWOT Analysis
Table 129. Janssen Pharmaceuticals(Johnson & Johnson) Recent Developments
Table 130. Hikma Pharmaceuticals USA Company Information
Table 131. Hikma Pharmaceuticals USA Description and Overview
Table 132. Hikma Pharmaceuticals USA Oxycodone Drug Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 133. Hikma Pharmaceuticals USA Oxycodone Drug Product and Services
Table 134. Hikma Pharmaceuticals USA Oxycodone Drug SWOT Analysis
Table 135. Hikma Pharmaceuticals USA Recent Developments
Table 136. Pfizer Company Information
Table 137. Pfizer Description and Overview
Table 138. Pfizer Oxycodone Drug Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 139. Pfizer Oxycodone Drug Product and Services
Table 140. Pfizer Oxycodone Drug SWOT Analysis
Table 141. Pfizer Recent Developments
Table 142. Sanofi-Aventis S.A. Company Information
Table 143. Sanofi-Aventis S.A. Description and Overview
Table 144. Sanofi-Aventis S.A. Oxycodone Drug Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 145. Sanofi-Aventis S.A. Oxycodone Drug Product and Services
Table 146. Sanofi-Aventis S.A. Oxycodone Drug SWOT Analysis
Table 147. Sanofi-Aventis S.A. Recent Developments
Table 148. Sun Pharmaceutical Industries Ltd. Company Information
Table 149. Sun Pharmaceutical Industries Ltd. Description and Overview
Table 150. Sun Pharmaceutical Industries Ltd. Oxycodone Drug Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 151. Sun Pharmaceutical Industries Ltd. Oxycodone Drug Product and Services
Table 152. Sun Pharmaceutical Industries Ltd. Oxycodone Drug SWOT Analysis
Table 153. Sun Pharmaceutical Industries Ltd. Recent Developments
Table 154. Oxynorm Company Information
Table 155. Oxynorm Description and Overview
Table 156. Oxynorm Oxycodone Drug Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 157. Oxynorm Oxycodone Drug Product and Services
Table 158. Oxynorm Oxycodone Drug SWOT Analysis
Table 159. Oxynorm Recent Developments
Table 160. OxyContin Company Information
Table 161. OxyContin Description and Overview
Table 162. OxyContin Oxycodone Drug Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 163. OxyContin Oxycodone Drug Product and Services
Table 164. OxyContin Oxycodone Drug SWOT Analysis
Table 165. OxyContin Recent Developments
Table 166. Endone Company Information
Table 167. Endone Description and Overview
Table 168. Endone Oxycodone Drug Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 169. Endone Oxycodone Drug Product and Services
Table 170. Endone Oxycodone Drug SWOT Analysis
Table 171. Endone Recent Developments
Table 172. Proladone Company Information
Table 173. Proladone Description and Overview
Table 174. Proladone Oxycodone Drug Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 175. Proladone Oxycodone Drug Product and Services
Table 176. Proladone Oxycodone Drug SWOT Analysis
Table 177. Proladone Recent Developments
Table 178. Targin Company Information
Table 179. Targin Description and Overview
Table 180. Targin Oxycodone Drug Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 181. Targin Oxycodone Drug Product and Services
Table 182. Targin Recent Developments
Table 183. Key Raw Materials Lists
Table 184. Raw Materials Key Suppliers Lists
Table 185. Oxycodone Drug Distributors List
Table 186. Oxycodone Drug Customers List
Table 187. Oxycodone Drug Market Trends
Table 188. Oxycodone Drug Market Drivers
Table 189. Oxycodone Drug Market Challenges
Table 190. Oxycodone Drug Market Restraints
Table 191. Research Programs/Design for This Report
Table 192. Key Data Information from Secondary Sources
Table 193. Key Data Information from Primary Sources
List of Figures
Figure 1. Oxycodone Drug Product Picture
Figure 2. Global Oxycodone Drug Market Size Growth Rate by Type, 2018 VS 2024 VS 2034 (US$ Million)
Figure 3. Global Oxycodone Drug Market Share by Type in 2024 & 2034
Figure 4. Pain Management Product Picture
Figure 5. Anesthesia Product Picture
Figure 6. Others Product Picture
Figure 7. Global Oxycodone Drug Market Size Growth Rate by Application, 2018 VS 2024 VS 2034 (US$ Million)
Figure 8. Global Oxycodone Drug Market Share by Application in 2024 & 2034
Figure 9. Hospitals & Clinics
Figure 10. Ambulatory Surgical Centers (ASCs)
Figure 11. Oxycodone Drug Report Years Considered
Figure 12. Global Oxycodone Drug Revenue, (US$ Million), 2018 VS 2024 VS 2034
Figure 13. Global Oxycodone Drug Revenue 2018-2034 (US$ Million)
Figure 14. Global Oxycodone Drug Revenue Market Share by Region in Percentage: 2024 Versus 2034
Figure 15. Global Oxycodone Drug Sales Quantity 2018-2034 (K Units)
Figure 16. Global Oxycodone Drug Sales Quantity Market Share by Region (2018-2023)
Figure 17. Global Oxycodone Drug Sales Quantity Market Share by Region (2024-2034)
Figure 18. North America Oxycodone Drug Sales Quantity YoY (2018-2034) & (K Units)
Figure 19. North America Oxycodone Drug Revenue YoY (2018-2034) & (US$ Million)
Figure 20. Europe Oxycodone Drug Sales Quantity YoY (2018-2034) & (K Units)
Figure 21. Europe Oxycodone Drug Revenue YoY (2018-2034) & (US$ Million)
Figure 22. China Oxycodone Drug Sales Quantity YoY (2018-2034) & (K Units)
Figure 23. China Oxycodone Drug Revenue YoY (2018-2034) & (US$ Million)
Figure 24. APAC Oxycodone Drug Sales Quantity YoY (2018-2034) & (K Units)
Figure 25. APAC Oxycodone Drug Revenue YoY (2018-2034) & (US$ Million)
Figure 26. Middle East, Africa and Latin America Oxycodone Drug Sales Quantity YoY (2018-2034) & (K Units)
Figure 27. Middle East, Africa and Latin America Oxycodone Drug Revenue YoY (2018-2034) & (US$ Million)
Figure 28. The Top 10 and Top 5 Players Market Share by Oxycodone Drug Sales Quantity in 2024
Figure 29. The Top 10 and Top 5 Players Market Share by Oxycodone Drug Revenue in 2024
Figure 30. Oxycodone Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2024
Figure 31. Global Oxycodone Drug Sales Quantity Market Share by Type (2018-2034)
Figure 32. Global Oxycodone Drug Revenue Market Share by Type (2018-2034)
Figure 33. Global Oxycodone Drug Sales Quantity Market Share by Application (2018-2034)
Figure 34. Global Oxycodone Drug Revenue Market Share by Application (2018-2034)
Figure 35. North America Oxycodone Drug Revenue Market Share by Company in 2024
Figure 36. North America Oxycodone Drug Sales Quantity Market Share by Company in 2024
Figure 37. North America Oxycodone Drug Sales Quantity Market Share by Type (2018-2034)
Figure 38. North America Oxycodone Drug Revenue Market Share by Type (2018-2034)
Figure 39. North America Oxycodone Drug Sales Quantity Market Share by Application (2018-2034)
Figure 40. North America Oxycodone Drug Revenue Market Share by Application (2018-2034)
Figure 41. North America Oxycodone Drug Revenue Share by Country (2018-2034)
Figure 42. North America Oxycodone Drug Sales Quantity Share by Country (2018-2034)
Figure 43. United States Oxycodone Drug Revenue (2018-2034) & (US$ Million)
Figure 44. Canada Oxycodone Drug Revenue (2018-2034) & (US$ Million)
Figure 45. Europe Oxycodone Drug Sales Quantity Market Share by Company in 2024
Figure 46. Europe Oxycodone Drug Revenue Market Share by Company in 2024
Figure 47. Europe Oxycodone Drug Sales Quantity Market Share by Type (2018-2034)
Figure 48. Europe Oxycodone Drug Revenue Market Share by Type (2018-2034)
Figure 49. Europe Oxycodone Drug Sales Quantity Market Share by Application (2018-2034)
Figure 50. Europe Oxycodone Drug Revenue Market Share by Application (2018-2034)
Figure 51. Europe Oxycodone Drug Revenue Share by Country (2018-2034)
Figure 52. Europe Oxycodone Drug Sales Quantity Share by Country (2018-2034)
Figure 53. Germany Oxycodone Drug Revenue (2018-2034) & (US$ Million)
Figure 54. France Oxycodone Drug Revenue (2018-2034) & (US$ Million)
Figure 55. U.K. Oxycodone Drug Revenue (2018-2034) & (US$ Million)
Figure 56. Italy Oxycodone Drug Revenue (2018-2034) & (US$ Million)
Figure 57. Russia Oxycodone Drug Revenue (2018-2034) & (US$ Million)
Figure 58. China Oxycodone Drug Sales Quantity Market Share by Company in 2024
Figure 59. China Oxycodone Drug Revenue Market Share by Company in 2024
Figure 60. China Oxycodone Drug Sales Quantity Market Share by Type (2018-2034)
Figure 61. China Oxycodone Drug Revenue Market Share by Type (2018-2034)
Figure 62. China Oxycodone Drug Sales Quantity Market Share by Application (2018-2034)
Figure 63. China Oxycodone Drug Revenue Market Share by Application (2018-2034)
Figure 64. APAC Oxycodone Drug Sales Quantity Market Share by Company in 2024
Figure 65. APAC Oxycodone Drug Revenue Market Share by Company in 2024
Figure 66. APAC Oxycodone Drug Sales Quantity Market Share by Type (2018-2034)
Figure 67. APAC Oxycodone Drug Revenue Market Share by Type (2018-2034)
Figure 68. APAC Oxycodone Drug Sales Quantity Market Share by Application (2018-2034)
Figure 69. APAC Oxycodone Drug Revenue Market Share by Application (2018-2034)
Figure 70. APAC Oxycodone Drug Revenue Share by Region (2018-2034)
Figure 71. APAC Oxycodone Drug Sales Quantity Share by Region (2018-2034)
Figure 72. Japan Oxycodone Drug Revenue (2018-2034) & (US$ Million)
Figure 73. South Korea Oxycodone Drug Revenue (2018-2034) & (US$ Million)
Figure 74. China Taiwan Oxycodone Drug Revenue (2018-2034) & (US$ Million)
Figure 75. Southeast Asia Oxycodone Drug Revenue (2018-2034) & (US$ Million)
Figure 76. India Oxycodone Drug Revenue (2018-2034) & (US$ Million)
Figure 77. Middle East, Africa and Latin America Oxycodone Drug Sales Quantity Market Share by Company in 2024
Figure 78. Middle East, Africa and Latin America Oxycodone Drug Revenue Market Share by Company in 2024
Figure 79. Middle East, Africa and Latin America Oxycodone Drug Sales Quantity Market Share by Type (2018-2034)
Figure 80. Middle East, Africa and Latin America Oxycodone Drug Revenue Market Share by Type (2018-2034)
Figure 81. Middle East, Africa and Latin America Oxycodone Drug Sales Quantity Market Share by Application (2018-2034)
Figure 82. Middle East, Africa and Latin America Oxycodone Drug Revenue Market Share by Application (2018-2034)
Figure 83. Middle East, Africa and Latin America Oxycodone Drug Sales Quantity Share by Country (2018-2034)
Figure 84. Middle East, Africa and Latin America Oxycodone Drug Revenue Share by Country (2018-2034)
Figure 85. Brazil Oxycodone Drug Revenue (2018-2034) & (US$ Million)
Figure 86. Mexico Oxycodone Drug Revenue (2018-2034) & (US$ Million)
Figure 87. Turkey Oxycodone Drug Revenue (2018-2034) & (US$ Million)
Figure 88. Israel Oxycodone Drug Revenue (2018-2034) & (US$ Million)
Figure 89. GCC Countries Oxycodone Drug Revenue (2018-2034) & (US$ Million)
Figure 90. Oxycodone Drug Value Chain
Figure 91. Oxycodone Drug Production Process
Figure 92. Channels of Distribution (Direct Vs Distribution)
Figure 93. Distributors Profiles
Figure 94. Bottom-up and Top-down Approaches for This Report
Figure 95. Data Triangulation
Figure 96. Key Executives Interviewed